Related Experiment Video

Updated: Apr 16, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the

Julio Finalet Ferreiro1, Julie Morscio2, Daan Dierickx3

  • 1KU Leuven, University of Leuven, Center for Human Genetics, Belgium.

Haematologica
|March 22, 2015
PubMed
Abstract

No abstract available in PubMed .

Keywords:
11qBurkitt lymphomaPTLDpost-transplant lymphoproliferative disease

More Related Videos

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.9K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K

Related Concept Videos